PRKCD and glioblastoma: In summary, our work reveals an underappreciated PKCδ-mediated axis of BTIC-microglia crosstalk, establishes proof-of-concept for the therapeutic reprogramming of resident brain microglia, and offers a detailed spatial-single-cell framework for developing next-generation GBM immunotherapies.